Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2291]
News [4641]
Articles [192]
Editorials [8]
Conferences [136]
elearning [9]
Chronic lymphocytic leukaemia: Transition to a new era
Prof Stephen Mulligan - Royal North Shore Hospital, Australia
Chronic lymphocytic leukaemia: Transition to a new era ( Prof Stephen Mulligan - Royal North Shore Hospital, Australia )
29 Apr 2016
Drugging “undruggable” transcription factor drivers in cancer
Dr John Bushweller - Unviersity of Virgina, Virginia, USA
Drugging “undruggable” transcription factor drivers in cancer ( Dr John Bushweller - Unviersity of Virgina, Virginia, USA )
28 Apr 2016
Elucidation and pharmacological targeting of tumour checkpoint dependencies
Dr Andrea Califano - Colombia University Medical Centre, New York, USA
Elucidation and pharmacological targeting of tumour checkpoint dependencies ( Dr Andrea Califano - Colombia University Medical Centre, New York, USA )
28 Apr 2016
New technology can potentially overcome CAR T-cell limitations
Dr Philip Low - Purdue University, West Lafayette, USA
New technology can potentially overcome CAR T-cell limitations ( Dr Philip Low - Purdue University, West Lafayette, USA )
27 Apr 2016
The future of haematopathology
Prof Alberto Zamo - University of Verona, Verona, Italy
The future of haematopathology ( Prof Alberto Zamo - University of Verona, Verona, Italy )
27 Apr 2016
Frontline therapy in young patients with myeloma
Prof Philippe Moreau - University of Nantes, Nantes, France
Frontline therapy in young patients with myeloma ( Prof Philippe Moreau - University of Nantes, Nantes, France )
27 Apr 2016
Genomics of childhood ALL
Prof Shai Izraeli - Sheba Medical Centre, Ramat Gan, Israel
Genomics of childhood ALL ( Prof Shai Izraeli - Sheba Medical Centre, Ramat Gan, Israel )
27 Apr 2016
Cell of origin role in cancer stem cell and GBM phenotype
Dr Luis Parada - Memorial Sloan Kettering Cancer Centre, New York, USA
Cell of origin role in cancer stem cell and GBM phenotype ( Dr Luis Parada - Memorial Sloan Kettering Cancer Centre, New York, USA )
27 Apr 2016
MINDACT breast cancer clinical trial: First results and impact on future trial...
Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium
MINDACT breast cancer clinical trial: First results and impact on future trial design ( Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
27 Apr 2016
BSH 2016: Expert discussion on front line care in CLL
Dr George Follows and Dr Andrew Zelenetz
BSH 2016: Expert discussion on front line care in CLL ( Dr George Follows and Dr Andrew Zelenetz )
27 Apr 2016
Risk of breast cancer after chest radiotherapy may be affected by genetics
Dr Lindsay Morton - National Cancer Institute, Bethesda, USA
Risk of breast cancer after chest radiotherapy may be affected by genetics ( Dr Lindsay Morton - National Cancer Institute, Bethesda, USA )
26 Apr 2016
Novel agents before and after stem cell transplantation for myeloma
Dr Enrique Ocio - Universidad de Salamanca, Salamanca, Spain
Novel agents before and after stem cell transplantation for myeloma ( Dr Enrique Ocio - Universidad de Salamanca, Salamanca, Spain )
12 Apr 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation